Journal
CRISPR JOURNAL
Volume 6, Issue 2, Pages 116-126Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/crispr.2022.0074
Keywords
-
Categories
Ask authors/readers for more resources
Using 2-3 gRNAs in parallel can enhance the sensitivity and speed of SARS-CoV-2 detection, accurately detecting positive and negative samples in a short time.
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) diagnostic methods have a large potential to effectively detect SARS-CoV-2 with sensitivity and specificity nearing 100%, comparable to quantitative polymerase chain reaction. Yet, there is room for improvement. Commonly, one guide CRISPR RNA (gRNA) is used to detect the virus DNA and activate Cas collateral activity, which cleaves a reporter probe. In this study, we demonstrated that using 2-3 gRNAs in parallel can create a synergistic effect, resulting in a 4.5 x faster cleaving rate of the probe and increased sensitivity compared to using individual gRNAs. The synergy is due to the simultaneous activation of CRISPR-Cas12a and the improved performance of each gRNA. This approach was able to detect as few as 10 viral copies of the N-gene of SARS-CoV-2 RNA after a preamplification step using reverse transcription loop-mediated isothermal amplification. The method was able to accurately detect 100% of positive and negative clinical samples in similar to 25 min using a fluorescence plate reader and similar to 45 min with lateral flow strips.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available